enGene Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
enGene Holdings Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Oct 2024Oct 2023Oct 2022Oct 2021
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.510.000.000.000.00
Gross Profit-0.510.000.000.000.00
Operating Expenses
Research & Development94.4838.3216.4615.4712.46
Selling, General & Administrative28.6923.989.603.963.41
Operating Expenses123.1762.3026.0619.4315.87
Operating Income-123.17-62.30-26.06-19.43-15.87
Other Income/Expense
Interest Income9.4310.411.120.130.03
Interest Expense2.992.80-4.95-1.42-5.02
Other Income/Expense5.86-0.48-10.57-3.02-4.20
Income
Income Before Tax-117.30-55.16-99.90-24.44-23.44
Income Tax Expense0.00-0.020.020.020.00
Net Income117.30-55.14-99.92-24.46-23.44
Net Income - Continuous Operations117.30-55.14-99.92-24.460.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-113.80-52.04-25.89-19.19-15.60
EBIT-114.31-52.36-26.06-19.43-15.87
Depreciation & Amortization0.510.320.180.240.27
Earnings Per Share
Basic EPS-2.00-1.00-151.00-44.00-6.00
Diluted EPS-2.00-1.00-151.00-44.00-6.00
Basic Shares Outstanding51.1237.780.690.663.56
Diluted Shares Outstanding51.1237.780.690.663.56